Medical Care Technologies Inc. (OTCID:MDCE) to Report Strongest Quarter of the Past Year in Upcoming Results
Initial software revenue and collectibles partnership sales are producing revenue, while management evaluates steps to limit future dilution.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medical Care Technologies (MDCE) expects third-quarter 2026 revenue to exceed every trailing quarter over the last twelve months. The anticipated performance reflects initial revenue from its first paid external software agreement and sales through its subsidiaries' collectibles partnership. Full results are due in the coming weeks.
Full-year 2025 revenue rose 63% to $1,071,812 from $656,402 in 2024, while net income increased 53% to $230,768. Management anticipates further revenue growth in coming quarters and throughout 2027, without projecting specific results. Share issuance over the past year diluted holders; management is evaluating capital-structure steps intended to limit future dilution, but has announced no specific action.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Q3 2026 revenue is expected to exceed every trailing quarter over the last twelve months.
- Moderate point2025 revenue rose 63% to $1,071,812 from $656,402 in 2024.
- Minor pointFirst paid external software agreement is generating initial software revenue.
- Minor pointSubsidiaries' collectibles partnership is generating sales activity.
- Minor point2025 net income rose 53% to $230,768 from the prior year.
- Minor point. Forward-looking: it has not happened yet and may not happen.Further revenue growth is anticipated by management in coming quarters and throughout 2027.
Negative
- Minor pointShare issuance over the past year diluted holders; capital-structure steps remain under evaluation, with no specific action announced.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MESA, AZ / ACCESS Newswire / October 16, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that it expects third-quarter 2026 results, scheduled for release in the coming weeks, to show the strongest quarterly revenue of the past calendar year.
The Company expects Q3 revenue to exceed every trailing quarter over the last twelve months. The anticipated strength is driven by two sources that are now producing: initial software revenue under the Company's first paid external software agreement, and sales activity through its subsidiaries' partnership with a multi-billion-dollar collectibles company. This follows full-year 2025 results in which MDCE reported revenue of
Management anticipates that revenue can continue to increase in the coming quarters and throughout 2027 as software execution advances and the collectibles partnership develops. That anticipation is tied to the commercial tracks already open. It is not a projection of specific future results.
The Company recognizes that share issuance over the past year has been a primary concern for shareholders. Management is focused on converting the capital that was raised into operating revenue and is evaluating capital-structure steps intended to reduce the impact of future dilution as those commercial tracks advance. No specific corporate action is being announced in this release.
"We expect to report our strongest quarter of the past year, driven by software and our collectibles partnership," said Marshall Perkins, CEO of Medical Care Technologies. "Shareholders have lived through the dilution. The priority now is to show that the capital raised is finally producing increasing revenues, and to build on that base in the quarters ahead."
Full third-quarter results will be released in the coming weeks. The Company is not providing specific revenue or earnings figures at this time.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://www.medicalcaretechnologies.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Website: https://www.medicalcaretechnologies.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does MDCE expect for third-quarter 2026 revenue?
MDCE expects Q3 2026 revenue to exceed every trailing quarter over the last twelve months. Initial software revenue and sales through its subsidiaries' collectibles partnership underpin that expectation. Full results are scheduled for release in the coming weeks.
Has MDCE announced a specific action to address dilution?
No specific corporate action has been announced. Management is evaluating capital-structure steps intended to reduce the impact of future dilution as its commercial activities advance.